$CNK

Gierhart Wanda Marie sold (to issuer) $331K of CNK

Gierhart Wanda Marie (Chief Marketing & Content Ofc) sold (to issuer) 9,450 shares of Cinemark Holdings, Inc. (CNK) at $35.00 ($0.33M total) on 2026-07-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gierhart Wanda Marie
Published Jul 30, 2026, 8:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNK
Neutral
high confidence
Mentioned
$CNK
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The disclosed sale is pre-arranged under a Rule 10b5-1 plan, which generally limits the informational content for near-term valuation.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation suggests it is not a fresh fundamental signal.

03

What to watch

The filing does not disclose any new business development, earnings, or risk event; traders should avoid over-weighting the sale without corroborating catalysts.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-30, transaction dated 2026-07-28

Background

The article is an SEC Form 4 insider transaction for Cinemark Holdings, Inc. (CNK) by its Chief Marketing & Content Officer.

Company-level read

Ticker impact

$CNKNeutralHigh confidence
Context

Cinemark officer Gierhart Wanda Marie sold 9,450 shares at $35.00 via a Rule 10b5-1 plan, reducing holdings to 58,082.

Expected impact

Low near-term impact; any reaction is likely muted unless paired with other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction, but it explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector read-through; this is company-specific insider trading with no operational or guidance change disclosed.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can coincide with routine liquidity needs and do not necessarily reflect bearish expectations.

Key entities

  • Cinemark Holdings, Inc.

    CNK, subject of the Form 4 insider sale disclosure.

  • Gierhart Wanda Marie

    Chief Marketing & Content Officer who sold 9,450 shares to the issuer at $35.00/share.

Related articles

$CNKMed

Cinemark Holdings, Inc. (CNK): Results of Operations and Financial Condition

Cinemark Holdings, Inc. (CNK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cnk-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 CINEMARK HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Generated all-time high quarterly revenue of $1.1 billion with records across all major revenue categories Delivered Net Income of $141 million, an increase of nearly

$IMAXMed

Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks By Investing.com

Christopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.

$TSCOMed

Tractor Supply downgrade, Five Below upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes across retail, software, media, telecom infrastructure, and industrials. Mizuho downgraded Tractor Supply (TSCO) to Neutral, cutting its FY26 outlook, while upgrading Five Below (FIVE) to Outperform with a $220 target. Goldman upgraded Toast (TOST) to Buy ($36), and other firms adjusted targets for Sarepta (SRPT), Cinemark (CNK), American Tower (AMT), and more.